Publication
Antagonist G-targeted liposomes for improved delivery of anticancer drugs in small cell lung carcinoma
dc.contributor.author | Carvalheiro, Manuela | |
dc.contributor.author | Ferreira-Silva, Margarida | |
dc.contributor.author | Holovanchuk, Denys | |
dc.contributor.author | Marinho, H. Susana | |
dc.contributor.author | Moreira, João Nuno | |
dc.contributor.author | Soares, Helena | |
dc.contributor.author | Corvo, M. Luisa | |
dc.contributor.author | Cruz, Maria Eugénia M. | |
dc.date.accessioned | 2022-03-04T13:23:42Z | |
dc.date.available | 2024-03-01T01:30:21Z | |
dc.date.issued | 2022-01 | |
dc.description | FCT_UID/Multi/00612/2019. FCT_UIDB/00100/2020. FCT_UIDP/00100/2020. | pt_PT |
dc.description.abstract | Ligand-mediated targeted liposomes have the potential to increase the therapeutic efficacy of anticancer drugs. This work aimed to evaluate the ability of antagonist G, a peptide targeting agent capable of blocking the action of multiple neuropeptides, to selectivity improve targeting and internalization of liposomal formulations (long-circulating liposomes, LCL, and stabilized antisense lipid particles containing ionizable amino lipid, SALP) to H69 and H82 small cell lung carcinoma (SCLC) cell lines. Antagonist G-targeted LCL and SALP were prepared by two different methods (either by direct covalent linkage at activated PEG grafted onto the liposomal surface or by post-insertion of DSPE-PEG-antagonist-G-conjugates into pre-formed liposomes). Association of the liposomal formulations with target SCLC cells was studied by fluorescence microscopy using fluorescence-labeled liposomes and confirmed quantitatively with [3H]-CHE-labelled liposomes. An antisense oligodeoxynucleotide against the overexpressed oncogene c-myc(as(c-myc)) was efficiently loaded into SALP formulations, the encapsulation efficiency decreased due to the inclusion of the targeting ligand. Also, liposome size was affected by as(c-myc) physical-chemical properties. The amount of antagonist G linked to the surface of the liposomal formulations was dependent on the coupling method and lipid composition used. Covalent attachment of antagonist G increased liposomes' cellular association and internalization via receptor-mediated and clathrin-dependent endocytosis, as assessed in SCLC cell lines. Biodistribution studies in healthy mice revealed a preferential lung accumulation of antagonist G-targeted SALP as compared to the non-targeted counterpart. Lung levels of the former were up to 3-fold higher 24 h after administration, highlighting their potential to be used as delivery vectors for SCLC treatment. | pt_PT |
dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
dc.identifier.citation | Carvalheiro M, Ferreira-Silva M, Holovanchuk D, Marinho S, Moreira JN, Soares H, et al. Antagonist G-targeted liposomes for improved delivery of anticancer drugs in small cell lung carcinoma. Int J Pharmaceutics. 2022;612:121380. | pt_PT |
dc.identifier.doi | 10.1016/j.ijpharm.2021.121380 | pt_PT |
dc.identifier.uri | http://hdl.handle.net/10400.21/14382 | |
dc.language.iso | eng | pt_PT |
dc.peerreviewed | yes | pt_PT |
dc.publisher | Elsevier | pt_PT |
dc.relation | FCT_UID/Multi/00612/2019 | pt_PT |
dc.relation | FCT_UIDB/00100/2020 | pt_PT |
dc.relation | FCT_UIDP/00100/2020 | pt_PT |
dc.relation.publisherversion | https://www.sciencedirect.com/science/article/pii/S0378517321011868 | pt_PT |
dc.subject | Antineoplastic agents | pt_PT |
dc.subject | Therapeutic use | pt_PT |
dc.subject | Drug delivery systems | pt_PT |
dc.subject | Liposomes | pt_PT |
dc.subject | Lung neoplasms | pt_PT |
dc.subject | Drug therapy | pt_PT |
dc.subject | Oligopeptides | pt_PT |
dc.subject | Small cell lung carcinoma | pt_PT |
dc.subject | Tissue distribution | pt_PT |
dc.subject | FCT_UID/Multi/00612/2019 | pt_PT |
dc.subject | FCT_UIDB/00100/2020 | pt_PT |
dc.subject | FCT_UIDP/00100/2020 | pt_PT |
dc.title | Antagonist G-targeted liposomes for improved delivery of anticancer drugs in small cell lung carcinoma | pt_PT |
dc.type | journal article | |
dspace.entity.type | Publication | |
oaire.citation.startPage | 121380 | pt_PT |
oaire.citation.title | International Journal of Pharmaceutics | pt_PT |
oaire.citation.volume | 612 | pt_PT |
rcaap.rights | openAccess | pt_PT |
rcaap.type | article | pt_PT |
Files
Original bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- Antagonist G-targeted liposomes for improved delivery of anticancer drugs in small cell lung carcinoma.pdf
- Size:
- 5.98 MB
- Format:
- Adobe Portable Document Format